9,10-ANTHRAQUINONE
General Information
Mainterm | 9,10-ANTHRAQUINONE |
CAS Reg.No.(or other ID) | 84-65-1 |
Regnum |
176.170 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 6780 |
IUPAC Name | anthracene-9,10-dione |
InChI | InChI=1S/C14H8O2/c15-13-9-5-1-2-6-10(9)14(16)12-8-4-3-7-11(12)13/h1-8H |
InChI Key | RZVHIXYEVGDQDX-UHFFFAOYSA-N |
Canonical SMILES | C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3C2=O |
Molecular Formula | C14H8O2 |
Wikipedia | anthraquinone |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 208.216 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 0 |
Complexity | 261.0 |
CACTVS Substructure Key Fingerprint | A A A D c c B w M A A A A A A A A A A A A A A A A A A A A A A A A A A w Y M A A A A A A A A D B Q A A A G g A A A A A A D A S A m A A w A I A A A A C I A q B S A A A C A A A k A A A I i A E A A M g I I D K A F R C A I Q A g g A A I i Y c J i M C O g A A A A A A Q A A C A A A Q A A C A A A A A A A A A A A A = = |
Topological Polar Surface Area | 34.1 |
Monoisotopic Mass | 208.052 |
Exact Mass | 208.052 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 16 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9653 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.8682 |
P-glycoprotein Substrate | Non-substrate | 0.6975 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7233 |
Non-inhibitor | 0.8846 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8262 |
Distribution | ||
Subcellular localization | Mitochondria | 0.7255 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.7896 |
CYP450 2D6 Substrate | Non-substrate | 0.9116 |
CYP450 3A4 Substrate | Non-substrate | 0.7148 |
CYP450 1A2 Inhibitor | Inhibitor | 0.9357 |
CYP450 2C9 Inhibitor | Inhibitor | 0.5919 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.6483 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.6245 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9241 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7247 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9185 |
Non-inhibitor | 0.9072 | |
AMES Toxicity | AMES toxic | 0.8554 |
Carcinogens | Non-carcinogens | 0.9132 |
Fish Toxicity | High FHMT | 0.7544 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9875 |
Honey Bee Toxicity | High HBT | 0.7268 |
Biodegradation | Not ready biodegradable | 0.5648 |
Acute Oral Toxicity | III | 0.4904 |
Carcinogenicity (Three-class) | Non-required | 0.5893 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -4.2800 | LogS |
Caco-2 Permeability | 1.8821 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.7726 | LD50, mol/kg |
Fish Toxicity | 0.6457 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 1.3267 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Benzenoids |
Class | Anthracenes |
Subclass | Anthraquinones |
Intermediate Tree Nodes | Not available |
Direct Parent | Anthraquinones |
Alternative Parents | |
Molecular Framework | Aromatic homopolycyclic compounds |
Substituents | Anthraquinone - 9,10-anthraquinone - Aryl ketone - Ketone - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Aromatic homopolycyclic compound |
Description | This compound belongs to the class of organic compounds known as anthraquinones. These are organic compounds containing either anthracene-9,10-quinone, 1,4-anthraquinone, or 1,2-anthraquinone. |
From ClassyFire